Dusseldorf - Delayed Quote EUR
Green Thumb Industries Inc (R9U2.DU)
5.11
+0.26
+(5.26%)
At close: May 16 at 7:31:57 PM GMT+2
Loading Chart for R9U2.DU
- Previous Close
4.85 - Open
4.92 - Bid --
- Ask --
- Day's Range
4.92 - 5.11 - 52 Week Range
4.28 - 11.89 - Volume
0 - Avg. Volume
1 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: R9U2.DU
View MorePerformance Overview: R9U2.DU
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
R9U2.DU
29.05%
S&P/TSX Composite index (^GSPTSE)
5.49%
1-Year Return
R9U2.DU
59.77%
S&P/TSX Composite index (^GSPTSE)
16.47%
3-Year Return
R9U2.DU
58.51%
S&P/TSX Composite index (^GSPTSE)
28.53%
5-Year Return
R9U2.DU
81.41%
S&P/TSX Composite index (^GSPTSE)
77.42%
Compare To: R9U2.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
5.11
+5.26%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3875
-0.15%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0431
+2.62%
Mkt Cap EUR 27.936M
Industry Drug Manufacturers—Specialty & Generic
1.8930
+2.21%
Mkt Cap EUR 259.008M
Industry Drug Manufacturers—Specialty & Generic
0.4155
+9.63%
Mkt Cap EUR 449.28M
Industry Drug Manufacturers—Specialty & Generic
0.4159
+9.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.3960
+17.11%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4066
+8.37%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.5965
-1.16%
Mkt Cap EUR 214.234M
Industry Drug Manufacturers—Specialty & Generic
Statistics: R9U2.DU
View MoreValuation Measures
As of 5/16/2025
Market Cap
1.20B
Enterprise Value
1.48B
Trailing P/E
27.21
Forward P/E
24.94
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.21
Price/Book (mrq)
0.75
Enterprise Value/Revenue
1.45
Enterprise Value/EBITDA
4.51
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--